TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice

Cancer peptide vaccines are a promising cancer immunotherapy that can induce cancer-specific cytotoxic T lymphocytes (CTLs) in tumors. However, recent clinical trials of cancer vaccines have revealed that the efficacy of the vaccines is limited. Targeting single antigens and vaccination with short p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yuki, Wada, Hiroshi, Goto, Risa, Osada, Toshihiro, Yamamura, Keisuke, Fukaya, Satoshi, Shimizu, Atsushi, Okubo, Mitsuru, Minamiguchi, Kazuhisa, Ikizawa, Koichi, Sasaki, Eiji, Utsugi, Teruhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560884/
https://www.ncbi.nlm.nih.gov/pubmed/33057061
http://dx.doi.org/10.1038/s41598-020-74187-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560884/
https://www.ncbi.nlm.nih.gov/pubmed/33057061
http://dx.doi.org/10.1038/s41598-020-74187-6

Ejemplares similares